Effects of Urate-Lowering Therapy on Risk of Hyperlipidemia in Gout by a Population-Based Cohort Study and on In Vitro Hepatic Lipogenesis-Related Gene Expression

• Hauptverfasser: Yi-Jen Fang (Verfasst von), Tien-Yuan Wu (Verfasst von), Cheng-Li Lin (Verfasst von), Chih-Yang Su (Verfasst von), Jia-Rong Li (Verfasst von), Yun-Lung Chung (Verfasst von), Ni Tien (Verfasst von), Yun-Ping Lim (Verfasst von)
• Format: Buch
• Veröffentlicht: Hindawi Limited, 2020-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Patients with gout are at a higher risk of cardiovascular disease, which is associated with hyperlipidemia. Management of gout in Taiwan is poor, and the association between urate-lowering therapy (ULT) among gout patients and hyperlipidemia is unclear. We conducted a retrospective cohort study usin...